MedPath

Study on safety and efficacy of mFOLFOX6 after exposure to an immune checkpoint inhibitor in advanced gastric cancer

Not Applicable
Recruiting
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000036157
Lead Sponsor
Kyoto Katsura Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

1) Severe complications 2) With active infection 3) Past history of severe hypersensitivity to drugs 4) Pregnant women, or women with the possibility of the pregnancy, Men who want let to pregnancy 5) Patients judged inappropriate for the study by the physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath